Select Publications
Journal articles
2019, 'Oligometastatic Disease in NSCLC — Not Just Wishful Thinking?', Journal of Thoracic Oncology, 14, pp. 2042 - 2045, http://dx.doi.org/10.1016/j.jtho.2019.10.008
,2019, 'Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria - Interim ILST Findings', JOURNAL OF THORACIC ONCOLOGY, 14, pp. S4 - S5, http://dx.doi.org/10.1016/j.jtho.2019.08.055
,2019, 'Patterns of care for stage III non–small cell lung cancer in Australia', Asia-Pacific Journal of Clinical Oncology, 15, pp. 93 - 100, http://dx.doi.org/10.1111/ajco.13140
,2019, 'Electronic cigarettes in physician practice: a complex debate', Internal Medicine Journal, 49, pp. 438 - 445, http://dx.doi.org/10.1111/imj.14256
,2019, 'Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer', Oncogene, 38, pp. 1661 - 1675, http://dx.doi.org/10.1038/s41388-018-0536-1
,2019, 'Tobacco and electronic nicotine delivery systems regulation', Translational Lung Cancer Research, 8, pp. S67 - S76, http://dx.doi.org/10.21037/tlcr.2019.03.13
,2019, 'ES13.03 Foundation for a Smoke Free Future: Funding Opportunities or Smoke Screen for the Tobacco Industry?', Journal of Thoracic Oncology, 14, pp. S47 - S47, http://dx.doi.org/10.1016/j.jtho.2019.08.128
,2018, 'Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi process', Respirology, 23, pp. 927 - 934, http://dx.doi.org/10.1111/resp.13307
,2018, 'Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study', Lung Cancer, 124, pp. 199 - 204, http://dx.doi.org/10.1016/j.lungcan.2018.07.032
,2018, 'Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol', JOURNAL OF THORACIC ONCOLOGY, 13, pp. S362 - S363, http://dx.doi.org/10.1016/j.jtho.2018.08.332
,2018, 'Tobacco cessation in lung cancer screening-do we have the evidence?', Translational Lung Cancer Research, 7, pp. S270 - S274, http://dx.doi.org/10.21037/tlcr.2018.09.09
,2018, '“Teachable Moment” Interventions in Lung Cancer: Why Action Matters', Journal of Thoracic Oncology, 13, pp. 603 - 605, http://dx.doi.org/10.1016/j.jtho.2018.02.020
,2018, 'Cannabis Use, Lung Cancer, and Related Issues', Journal of Thoracic Oncology, 13, pp. 480 - 487, http://dx.doi.org/10.1016/j.jtho.2017.12.013
,2018, 'Tobacco-Free Investment: Harnessing the Power of the Finance Industry in Comprehensive Tobacco Control', QUT Law Review, 17, pp. 161 - 161, http://dx.doi.org/10.5204/qutlr.v17i2.699
,2018, 'Evidence-practice gaps in lung cancer: A scoping review', European Journal of Cancer Care, 27, http://dx.doi.org/10.1111/ecc.12588
,2018, 'The Influence of Histologic Subtype in Predicting Survival of Lung Cancer Patients with Spinal Metastases', Clinical Spine Surgery, 31, pp. E1 - E7, http://dx.doi.org/10.1097/BSD.0000000000000475
,2018, 'Acute Pulmonary Embolism: An update on management', Cardiology Today, 8, pp. 62 - 68
,2017, 'Young low and middle-income country (LMIC) smokers- implications for global tobacco control', Translational Lung Cancer Research, 6, pp. S44 - S46, http://dx.doi.org/10.21037/tlcr.2017.10.11
,2017, 'Scientific Advances in Thoracic Oncology 2016', Journal of Thoracic Oncology, 12, pp. 1183 - 1209, http://dx.doi.org/10.1016/j.jtho.2017.05.019
,2017, 'The Obesity Paradox—What Does It Mean for Lung Cancer Surgery?', Journal of Thoracic Oncology, 12, pp. 1174 - 1176, http://dx.doi.org/10.1016/j.jtho.2017.06.011
,2017, 'Pathways to lung cancer diagnosis: A Qualitative study of patients and general practitioners about diagnostic and pretreatment intervals', Annals of the American Thoracic Society, 14, pp. 742 - 753, http://dx.doi.org/10.1513/AnnalsATS.201610-817OC
,2017, 'Closing evidence-practice gaps in lung cancer: Results from multi-methods priority setting in the clinical context', Asia-Pacific Journal of Clinical Oncology, 13, pp. 28 - 36, http://dx.doi.org/10.1111/ajco.12499
,2017, 'P1.04-003 The International Lung Screen Trial: A Multi-Center Study to Evaluate LDCT Screening Selection Criteria and Nodule Management', Journal of Thoracic Oncology, 12, pp. S1973 - S1973, http://dx.doi.org/10.1016/j.jtho.2017.09.862
,2017, 'P3.07-019 AMDAT Lung, An Ideal Lung Cancer MDT Dataset', Journal of Thoracic Oncology, 12, pp. S1442 - S1442, http://dx.doi.org/10.1016/j.jtho.2016.11.2210
,2016, 'Tobacco Control and Tobacco Cessation in Lung Cancer - Too Little, Too Late?', Seminars in Respiratory and Critical Care Medicine, 37, pp. 649 - 658, http://dx.doi.org/10.1055/s-0036-1592115
,2016, 'Slowing the Titanic: China's Epic Struggle with Tobacco', Journal of Thoracic Oncology, 11, pp. 2053 - 2065, http://dx.doi.org/10.1016/j.jtho.2016.07.020
,2015, 'Improving Pathways to Early Lung Cancer Diagnosis: Process Mapping and Qualitative Analysis', JOURNAL OF THORACIC ONCOLOGY, 10, pp. S398 - S398, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370365101412&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Patient Advocates in the Lung Cancer Diagnostic Pathway: A Qualitative Study of Interviews with Lung Cancer Patients and Their Caregivers', JOURNAL OF THORACIC ONCOLOGY, 10, pp. S226 - S226, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370365100365&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Monoclonal precursor T-cell infiltrate in recurrent thymoma: a case report', Pathology, 47, pp. 375 - 377, http://dx.doi.org/10.1097/PAT.0000000000000257
,2015, '500P Dependence of fluorodeoxyglucose avidity on tumour size in non-small cell lung cancer', Annals of Oncology, 26, pp. ix153 - ix153, http://dx.doi.org/10.1093/annonc/mdv534.04
,2014, 'Pulmonary artery stent for bronchial adenoid cystic carcinoma causing pulmonary artery stenosis', Respirology Case Reports, 2, pp. 39 - 41, http://dx.doi.org/10.1002/rcr2.42
,2014, 'High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non-squamous non-small-cell lung cancer', Internal Medicine Journal, 44, pp. 1188 - 1192, http://dx.doi.org/10.1111/imj.12587
,2013, 'IDENTIFYING EVIDENCE-PRACTICE GAPS IN LUNG CANCER AND PRIORITY SETTING WITH CLINICIANS IN NSW, AUSTRALIA', JOURNAL OF THORACIC ONCOLOGY, 8, pp. S699 - S700, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624903163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'AN EVALUATION OF THE MULTI-DISCIPLINARY APPROACH IN THE MANAGEMENT OF LUNG CANCER: A SINGLE-CENTRE EXPERIENCE', RESPIROLOGY, 18, pp. 68 - 68, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'EGFR MUTATIONS OCCUR COMMONLY IN NON-SQUAMOUS NSCLC IN SYDNEY', RESPIROLOGY, 18, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700252&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'A breath test for malignant mesothelioma using an electronic nose', European Respiratory Journal, 40, pp. 448 - 454, http://dx.doi.org/10.1183/09031936.00040911
,2011, 'MULTIMODALITY THERAPY IN MALIGNANT PLEURAL MESOTHELIOMA (MPM): SINGLE INSTITUTIONAL EXPERIENCE', JOURNAL OF THORACIC ONCOLOGY, 6, pp. S31 - S31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287990600113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2003, 'Use of computed tomography pulmonary angiography in the diagnosis of pulmonary embolism in patients with an intermediate probability ventilation/perfusion scan', Internal Medicine Journal, 33, pp. 74 - 78, http://dx.doi.org/10.1046/j.1445-5994.2003.00345.x
,2000, 'Persistent, progressive hypophosphataemia after voluntary hyperventilation', Clinical Science, 98, pp. 619 - 625, http://dx.doi.org/10.1042/cs0980619
,1999, 'Persistent, progressive hypophosphataemia after hyperventilation', Respirology, 4
,1997, 'Calcific atrial mass in end-stage renal failure', Nephrology Dialysis Transplantation, 12, pp. 807 - 810, http://dx.doi.org/10.1093/ndt/12.4.807
,Conference Papers
2023, 'Psychosocial consequences of lung cancer screening; early results from the Australian International Lung Screen Trial (ILST) cohort.', in Lung cancer, European Respiratory Society, presented at ERS International Congress 2023 abstracts, http://dx.doi.org/10.1183/13993003.congress-2023.pa1120
,2023, 'Psychosocial consequences of lung cancer screening; validation of an Australian English translation of a lung cancer-specific questionnaire.', in Lung cancer, European Respiratory Society, presented at ERS International Congress 2023 abstracts, http://dx.doi.org/10.1183/13993003.congress-2023.pa1121
,2023, 'Key stakeholder perspectives on smoking cessation support within lung cancer screening in Australia', in RESPIROLOGY, WILEY, pp. 17 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001002468800027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2023, 'What Strategies Are Recommended for Potential Implementation of a National Lung Cancer Screening in Australia?', in D14. CUTTING EDGE CONCEPTS IN BEHAVIORAL SCIENCES AND HEALTH SERVICES RESEARCH, American Thoracic Society, presented at American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC, http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6219
,2022, 'Australian Lung Cancer Survivors Experiences of Novel Treatments, Healthcare, and Ongoing Physical and Psychological Needs', in JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, pp. S502 - S502, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000858678101327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Education Messages and Strategies About Lung Cancer Screening: A Systematic Review', in JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, pp. S168 - S168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000858678100265&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Potential Drivers of Lung Cancer Screening Participation in Australia: A Qualitative Study to Inform Future Implementation', in JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, pp. S174 - S174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000858678100275&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Prospective Study of Lung Cancer Screening Criteria: USPSTF2013 vs PLCOm2012-International Lung Screening Trial (ILST) Results', in JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, pp. S881 - S881, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000709606500096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Lung Cancer Screening: What is the State of the Evidence about Implementation?', in JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, pp. S475 - S475, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000631349601254&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,